{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:32:03Z","timestamp":1791351123411,"version":"4.3.1"},"reference-count":39,"publisher":"Japanese Circulation Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1253\/circj.cj-14-0543","type":"journal-article","created":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T23:21:07Z","timestamp":1401924067000},"page":"1514-1519","source":"Crossref","is-referenced-by-count":24,"title":["Troponin I-Interacting Protein Kinase"],"prefix":"10.1253","volume":"78","author":[{"given":"Hind","family":"Lal","sequence":"first","affiliation":[{"name":"Center for Translational Medicine and Cardiology Division, Temple University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firdos","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Center for Translational Medicine and Cardiology Division, Temple University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Parikh","sequence":"additional","affiliation":[{"name":"Center for Translational Medicine and Cardiology Division, Temple University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Force","sequence":"additional","affiliation":[{"name":"Center for Translational Medicine and Cardiology Division, Temple University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. HausenloyDJ,YellonDM.Myocardial ischemia-reperfusion injury: A neglected therapeutic target.<i>J Clin Invest<\/i>2013;123:92\u2013100.","DOI":"10.1172\/JCI62874"},{"key":"2","unstructured":"2. GerczukPZ,KlonerRA.An update on cardioprotection: A review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials.<i>J Am Coll Cardiol<\/i>2012;59:969\u2013978."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. KlonerRA.Current state of clinical translation of cardioprotective agents for acute myocardial infarction.<i>Circ Res<\/i>2013;113:451\u2013463.","DOI":"10.1161\/CIRCRESAHA.112.300627"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. MinaminoT.Cardioprotection from ischemia\/reperfusion injury: Basic and translational research.<i>Circ J<\/i>2012;76:1074\u20131082.","DOI":"10.1253\/circj.CJ-12-0132"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. FrohlichGM,MeierP,WhiteSK,YellonDM,HausenloyDJ.Myocardial reperfusion injury: Looking beyond primary pci.<i>Eur Heart J<\/i>2013;34:1714\u20131722.","DOI":"10.1093\/eurheartj\/eht090"},{"key":"6","unstructured":"6. VagnozziRJ,GattoGJJr,KallanderLS,HoffmanNE,MallilankaramanK,BallardVL, et al.Inhibition of the cardiomyocyte-specific kinase TNNI3K limits oxidative stress, injury, and adverse remodeling in the ischemic heart.<i>Sci Transl Med<\/i>2013;5:207ra141."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. AbrahamDM,MarchukDA.Inhibition of the cardiomyocyte-specific troponin I-interacting kinase limits oxidative stress, injury, and adverse remodeling due to ischemic heart disease.<i>Circ Res<\/i>2014;114:938\u2013940.","DOI":"10.1161\/CIRCRESAHA.113.303238"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. WangX,WangJ,SuM,WangC,ChenJ,WangH, et al.TNNI3K, a cardiac-specific kinase, promotes physiological cardiac hypertrophy in transgenic mice.<i>PLoS One<\/i>2013;8:e58570, doi:org\/10.1371\/journal.pone.0058570.","DOI":"10.1371\/journal.pone.0058570"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. TangH,XiaoK,MaoL,RockmanHA,MarchukDA.Overexpression of TNNI3K, a cardiac-specific MAPKKK, promotes cardiac dysfunction.<i>J Mol Cell Cardiol<\/i>2013;54:101\u2013111.","DOI":"10.1016\/j.yjmcc.2012.10.004"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. LaiZF,ChenYZ,FengLP,MengXM,DingJF,WangLY, et al.Overexpression of TNNI3K, a cardiac-specific MAP kinase, promotes P19CL6-derived cardiac myogenesis and prevents myocardial infarction-induced injury.<i>Am J Physiol Heart Circ Physiol<\/i>2008;295:H708\u2013H716.","DOI":"10.1152\/ajpheart.00252.2008"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. WheelerFC,TangH,MarksOA,HadnottTN,ChuPL,MaoL, et al.TNNI3K modifies disease progression in murine models of cardiomyopathy.<i>PLoS Genet<\/i>2009;5:e1000647e1000647, doi:org\/10.1371\/journal.pgen.1000647.","DOI":"10.1371\/journal.pgen.1000647"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. ZhaoY,MengXM,WeiYJ,ZhaoXW,LiuDQ,CaoHQ, et al.Cloning and characterization of a novel cardiac-specific kinase that interacts specifically with cardiac troponin I.<i>J Mol Med (Berl)<\/i>2003;81:297\u2013304.","DOI":"10.1007\/s00109-003-0427-x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. WangH,ChenC,SongX,ChenJ,ZhenY,SunK, et al.Mef2c is an essential regulatory element required for unique expression of the cardiac-specific CARK gene.<i>J Cell Mol Med<\/i>2008;12:304\u2013315.","DOI":"10.1111\/j.1582-4934.2007.00155.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. HanniganGE,McDonaldPC,WalshMP,DedharS.Integrin-linked kinase: Not so \u2018pseudo\u2019 after all.<i>Oncogene<\/i>2011;30:4375\u20134385.","DOI":"10.1038\/onc.2011.177"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. HanniganGE,ColesJG,DedharS.Integrin-linked kinase at the heart of cardiac contractility, repair, and disease.<i>Circ Res<\/i>2007;100:1408\u20131414.","DOI":"10.1161\/01.RES.0000265233.40455.62"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. LalH,VermaSK,FosterDM,GoldenHB,ReneauJC,WatsonLE, et al.Integrins and proximal signaling mechanisms in cardiovascular disease.<i>Front Biosci<\/i>2009;14:2307\u20132334.","DOI":"10.2741\/3381"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. EdmondsonDG,LyonsGE,MartinJF,OlsonEN.MEF2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis.<i>Development<\/i>1994;120:1251\u20131263.","DOI":"10.1242\/dev.120.5.1251"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. OlsonEN,PerryM,SchulzRA.Regulation of muscle differentiation by the MEF2 family of MADS box transcription factors.<i>Dev Biol<\/i>1995;172:2\u201314.","DOI":"10.1006\/dbio.1995.0002"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. LinQ,SchwarzJ,BucanaC,OlsonEN.Control of mouse cardiac morphogenesis and myogenesis by transcription factor Mef2c.<i>Science<\/i>1997;276:1404\u20131407.","DOI":"10.1126\/science.276.5317.1404"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. XuJ,GongNL,BodiI,AronowBJ,BackxPH,MolkentinJD.Myocyte enhancer factors 2a and 2c induce dilated cardiomyopathy in transgenic mice.<i>J Biol Chem<\/i>2006;281:9152\u20139162.","DOI":"10.1074\/jbc.M510217200"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. van OortRJ,van RooijE,BourajjajM,SchimmelJ,JansenMA,van der NagelR, et al.Mef2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-induced heart failure.<i>Circulation<\/i>2006;114:298\u2013308.","DOI":"10.1161\/CIRCULATIONAHA.105.608968"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1134\/S0006297907110053"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. ImmenschuhS,Baumgart-VogtE.Peroxiredoxins, oxidative stress, and cell proliferation.<i>Antioxid Redox Signal<\/i>2005;7:768\u2013777.","DOI":"10.1089\/ars.2005.7.768"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. RigouletM,YoboueED,DevinA.Mitochondrial ROS generation and its regulation: Mechanisms involved in H(2)O(2) signaling.<i>Antioxid Redox Signal<\/i>2011;14:459\u2013468.","DOI":"10.1089\/ars.2010.3363"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. WangL,WangH,YeJ,XuRX,SongL,ShiN, et al.Adenovirus-mediated overexpression of cardiac troponin I-interacting kinase promotes cardiomyocyte hypertrophy.<i>Clin Exp Pharmacol Physiol<\/i>2011;38:278\u2013284.","DOI":"10.1111\/j.1440-1681.2011.05499.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. YajimaT,KnowltonKU.Viral myocarditis: From the perspective of the virus.<i>Circulation<\/i>2009;119:2615\u20132624.","DOI":"10.1161\/CIRCULATIONAHA.108.766022"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. CorstenMF,SchroenB,HeymansS.Inflammation in viral myocarditis: Friend or foe?<i>Trends Mol Med<\/i>2012;18:426\u2013437.","DOI":"10.1016\/j.molmed.2012.05.005"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. DennertR,CrijnsHJ,HeymansS.Acute viral myocarditis.<i>Eur Heart J<\/i>2008;29:2073\u20132082.","DOI":"10.1093\/eurheartj\/ehn296"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. BowlesNE,NiJ,KearneyDL,PauschingerM,SchultheissHP,McCarthyR, et al.Detection of viruses in myocardial tissues by polymerase chain reaction: Evidence of adenovirus as a common cause of myocarditis in children and adults.<i>J Am Coll Cardiol<\/i>2003;42:466\u2013472.","DOI":"10.1016\/S0735-1097(03)00648-X"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. EsfandiareiM,McManusBM.Molecular biology and pathogenesis of viral myocarditis.<i>Annu Rev Pathol<\/i>2008;3:127\u2013155.","DOI":"10.1146\/annurev.pathmechdis.3.121806.151534"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. KindermannI,BarthC,MahfoudF,UkenaC,LenskiM,YilmazA, et al.Update on myocarditis.<i>J Am Coll Cardiol<\/i>2012;59:779\u2013792.","DOI":"10.1016\/j.jacc.2011.09.074"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. WiltshireSA,Leiva-TorresGA,VidalSM.Quantitative trait locus analysis, pathway analysis, and consomic mapping show genetic variants of TNNI3K, FPGT, or H28 control susceptibility to viral myocarditis.<i>J Immunol<\/i>2011;186:6398\u20136405.","DOI":"10.4049\/jimmunol.1100159"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. WeiYJ,CuiCJ,HuangYX,ZhangXL,ZhangH,HuSS.Upregulated expression of cardiac ankyrin repeat protein in human failing hearts due to arrhythmogenic right ventricular cardiomyopathy.<i>Eur J Heart Fail<\/i>2009;11:559\u2013566.","DOI":"10.1093\/eurjhf\/hfp049"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. LodderEM,SciclunaBP,MilanoA,SunAY,TangH,RemmeCA, et al.Dissection of a quantitative trait locus for PR interval duration identifies TNNI3K as a novel modulator of cardiac conduction.<i>PLoS Genet<\/i>2012;8:e1003113, doi:org\/10.1371\/journal.pgen.1003113.","DOI":"10.1371\/journal.pgen.1003113"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. CurranJ,MohlerPJ.Defining the pathways underlying the prolonged PR interval in atrioventricular conduction disease.<i>PLoS Genet<\/i>2012;8:e1003154, doi:org\/10.1371\/journal.pgen.1003154.","DOI":"10.1371\/journal.pgen.1003154"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20592"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. GraffM,NgwaJS,WorkalemahuT,HomuthG,SchipfS,TeumerA, et al.Genome-wide analysis of BMI in adolescents and young adults reveals additional insight into the effects of genetic loci over the life course.<i>Hum Mol Genet<\/i>2013;22:3597\u20133607.","DOI":"10.1093\/hmg\/ddt205"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. McCafferyJM,PapandonatosGD,PeterI,HugginsGS,RaynorHA,DelahantyLM, et al.Obesity susceptibility loci and dietary intake in the Look AHEAD trial.<i>Am J Clin Nutr<\/i>2012;95:1477\u20131486.","DOI":"10.3945\/ajcn.111.026955"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2011.237"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/78\/7\/78_CJ-14-0543\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:49:17Z","timestamp":1649206157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/78\/7\/78_CJ-14-0543\/_article"}},"subtitle":["\u2013 A Novel Cardiac-Specific Kinase, Emerging as a Molecular Target for the Treatment of Cardiac Disease \u2013"],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-14-0543","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}